|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 December 2001 | Volume 135 Issue 11 | Pages 977-981
Background: An abundance of ovarian hormones is assumed to be a major contributor to the low incidence of ischemic heart disease in premenopausal women. However, the effects of ovarian hormones remain undetermined.
Objective: To examine whether the variation in ovarian hormone levels throughout a menstrual cycle affects myocardial ischemia in women with variant angina.
Design: Prospective, observational study.
Setting: University medical center in Japan.
Participants: 10 premenopausal women with variant angina.
Measurements: Frequency of spontaneous ischemic episodes, flow-mediated dilation of brachial artery, and serum levels of estradiol and progesterone.
Results: Frequency of ischemic episodes was highest from the end of the luteal phase to the beginning of the menstrual phase and was lowest in the follicular phase. Flow-mediated vasodilation and estradiol levels were lowest from the end of the luteal phase to the beginning of the menstrual phase and were highest in the follicular phase.
Conclusions: In premenopausal women with variant angina, we documented a cyclic variation in endothelial function and the frequency of myocardial ischemia that was associated with the variation in estrogen levels.
Author and Article Information
From Kumamoto University School of Medicine, Kumamoto Regional Medical Center, and Kumamoto Aging Research Institute, Kumamoto, Japan.
Acknowledgments: The authors thank the patient volunteers for their outstanding patience and generosity, Yasunori Uragari for expert assistance with statistical analysis, and Noriko Kawano for help in many ways.
Grant Support: By a Grant for Clinical Vascular Function and by a Grant-in-Aid for Scientific Research (A12770346) from the Ministry of Education, Science, and Culture, Japan.
Requests for Single Reprints: Hiroaki Kawano, MD, PhD, Department of Cardiovascular Medicine, Kumamoto University School of Medicine, 1-1-1 Honjo, Kumamoto City 860-8556, Japan; e-mail, koumei{at}gpo.kumamoto-u.ac.jp.
Current Author Addresses: Drs. Kawano, Motoyama, Kugiyama, and Ogawa: Department of Cardiovascular Medicine, Kumamoto University School of Medicine, 1-1-1 Honjo, Kumamoto City 860-8556, Japan.
Dr. Ohgushi: Kumamoto Regional Medical Center, 5-16-10 Honjo, Kumamoto City 860-0811, Japan.
Dr. Yasue: Kumamoto Aging Research Institute, 6-8-1 Yamamuro, Kumamoto City 860-8518, Japan.
Author Contributions: Conception and design: H. Kawano, H. Yasue.
Analysis and interpretation of the data: H. Kawano, T. Motoyama,
Drafting of the article: H. Kawano, H. Yasue.
Critical revision of the article for important intellectual content: H. Kawano.
Final approval of the article: H. Kawano, T. Motoyama, M. Ohgushi, K. Kugiyama, H. Ogawa, H. Yasue.
Provision of study materials or participants: H. Kawano, T. Motoyama, M. Ohgushi, K. Kugiyama, H. Ogawa, H. Yasue.
Statistical expertise: H. Kawano.
Obtaining of funding: H. Kawano, H. Yasue.
Administrative, technical, or logistic support: K. Kugiyama, H. Ogawa, H. Yasue.
Collection and assembly of data: H. Kawano, T. Motoyama, M. Ohgushi. BRIEF COMMUNICATION
Menstrual Cyclic Variation of Myocardial Ischemia in Premenopausal Women with Variant Angina
![]()
Related articles in Annals:
This article has been cited by other articles:
![]() |
G. Han, H. Ma, R. Chintala, K. Miyake, D. J. R. Fulton, S. A. Barman, and R. E. White Nongenomic, endothelium-independent effects of estrogen on human coronary smooth muscle are mediated by type I (neuronal) NOS and PI3-kinase-Akt signaling Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H314 - H321. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sanders, J. Harris, J. Cooper, P. Gohlke, S. E Humphries, H. Montgomery, and D. R Woods Lack of change in serum angiotensin-converting enzyme activity during the menstrual cycle Journal of Renin-Angiotensin-Aldosterone System, December 1, 2006; 7(4): 231 - 235. [Abstract] [PDF] |
||||
![]() |
G. H. Tofler and J. E. Muller Triggering of Acute Cardiovascular Disease and Potential Preventive Strategies Circulation, October 24, 2006; 114(17): 1863 - 1872. [Full Text] [PDF] |
||||
![]() |
L. J. Shaw, C. N. Bairey Merz, C. J. Pepine, S. E. Reis, V. Bittner, S. F. Kelsey, M. Olson, B. D. Johnson, S. Mankad, B. L. Sharaf, et al. Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: Gender Differences in Traditional and Novel Risk Factors, Symptom Evaluation, and Gender-Optimized Diagnostic Strategies J. Am. Coll. Cardiol., February 7, 2006; 47(3_Suppl_S): S4 - S20. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Ridout, B. A. Parker, and D. N. Proctor Age and regional specificity of peak limb vascular conductance in women J Appl Physiol, December 1, 2005; 99(6): 2067 - 2074. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kitta, T. Nakamura, Y. Kodama, H. Takano, K. Umetani, D. Fujioka, Y. Saito, K.-i. Kawabata, J.-e. Obata, Y. Ichigi, et al. Endothelial Vasomotor Dysfunction in the Brachial Artery Is Associated With Late In-Stent Coronary Restenosis J. Am. Coll. Cardiol., August 16, 2005; 46(4): 648 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rickenlund, M. J. Eriksson, K. Schenck-Gustafsson, and A. L. Hirschberg Amenorrhea in Female Athletes Is Associated with Endothelial Dysfunction and Unfavorable Lipid Profile J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1354 - 1359. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Mieres, L. J. Shaw, A. Arai, M. J. Budoff, S. D. Flamm, W. G. Hundley, T. H. Marwick, L. Mosca, A. R. Patel, M. A. Quinones, et al. Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Coronary Artery Disease: Consensus Statement From the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association Circulation, February 8, 2005; 111(5): 682 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Bots, J. Westerink, T. J. Rabelink, and E. J.P. de Koning Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response Eur. Heart J., February 2, 2005; 26(4): 363 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-G. V. Giardina, H. J. Chen, R. R. Sciacca, and L. E. Rabbani Dynamic Variability of Hemostatic and Fibrinolytic Factors in Young Women J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6179 - 6184. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Keller and L. Lemberg Prinzmetal's Angina Am. J. Crit. Care., July 1, 2004; 13(4): 350 - 354. [Full Text] [PDF] |
||||
![]() |
H. Kawano Medical Care of Premenopausal Women with Coronary Artery Disease Ann Intern Med, August 6, 2002; 137(3): W1 - W1. [Full Text] [PDF] |
||||
![]() |
Menstrual Cycle Influences Symptoms and Vasodilation in Variant Angina Journal Watch Women's Health, February 5, 2002; 2002(205): 5 - 5. [Full Text] |
||||
![]() |
Correction: Blood Flow to the Heart during the Menstrual Cycle Ann Intern Med, February 5, 2002; 136(3): 253 - 253. [Full Text] [PDF] |
||||
![]() |
CAD Risk May Vary Over the Course of the Menstrual Cycle Journal Watch Cardiology, February 1, 2002; 2002(201): 5 - 5. [Full Text] |
||||
![]() |
Heart Disease in Women: Is It the Estrogen? Journal Watch Dermatology, January 30, 2002; 2002(130): 7 - 7. [Full Text] |
||||
![]() |
Heart Disease in Women: Is It the Estrogen? Journal Watch (General), December 28, 2001; 2001(1228): 2 - 2. [Full Text] |
||||
![]() |
P. Charney Coronary Artery Disease in Young Women: The Menstrual Cycle and Other Risk Factors Ann Intern Med, December 4, 2001; 135(11): 1002 - 1004. [Full Text] [PDF] |
||||